What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?

The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY

Does Alnylam Pharmaceuticals, Inc. pay dividends?

No, Alnylam Pharmaceuticals, Inc. does not pay dividends

What sector is Alnylam Pharmaceuticals, Inc. in?

Alnylam Pharmaceuticals, Inc. is in the Healthcare sector

What industry is Alnylam Pharmaceuticals, Inc. in?

Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry

What country is Alnylam Pharmaceuticals, Inc. based in?

Alnylam Pharmaceuticals, Inc. is headquartered in United States

When did Alnylam Pharmaceuticals, Inc. go public?

Alnylam Pharmaceuticals, Inc. initial public offering (IPO) was on June 1, 2004

Is Alnylam Pharmaceuticals, Inc. in the S&P 500?

No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index

Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?

Yes, Alnylam Pharmaceuticals, Inc. is included in the NASDAQ 100 index

Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?

No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index

When was Alnylam Pharmaceuticals, Inc. last earnings report?

Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026

When does Alnylam Pharmaceuticals, Inc. report earnings?

The next expected earnings date for Alnylam Pharmaceuticals, Inc. is October 29, 2026

ALNY Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, ALNY price is $239.56, down -2.42% on September 18, 2026
Current Price All-Time High: ALNY price is currently -51.66% below its historical high of $495.55 set on October 20, 2025
Market Cap: ALNY current market cap is $32B, down -45.87% year-over-year
PE Ratio: ALNY current PE ratio is 40.45
Revenue: ALNY current annual revenue is $3.71B, up +65.19% year-over-year
Next Earnings: The next earnings release for ALNY is on October 29, 2026

Profile

Company profile for Alnylam Pharmaceuticals, Inc. (ALNY)
Metric	Value
Full Name	Alnylam Pharmaceuticals, Inc.
Ticker	NASDAQ: ALNY
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology
Country	United States
IPO	Jun 1, 2004
Indexes	NDX — NASDAQ 100 Index
Website	alnylam.com
Employees	2,230

Key Metrics

Alnylam Pharmaceuticals, Inc. Key Details
Metric	Value	Date
Price	$239.56	Sep 18, 26
Price, 1D Change	-2.42%	Sep 18, 26
Market Cap	$32B	Sep 18, 26
	-	Sep 18, 26
PE Ratio	40.45	Sep 18, 26
Beta	0.40	Sep 18, 26
Revenue	$3.71B	Dec 31, 25
Revenue, 1Y Change	+65.19%	Dec 31, 25
EPS	$2.33	Dec 31, 25
EPS, 1Y Change	+206.91%	Dec 31, 25

Events

Alnylam Pharmaceuticals, Inc. Events
Metric	Value	Date
Next Earnings		Oct 29, 26
Last Qtr. Earnings		Jul 30, 26
Last Ann. Earnings		Feb 12, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

ALNY Estimates
Metric	Value	Date
EPS	$2.33	Dec 31, 25
EPS Estimate	$8.85	N/A
EPS Est. Change	+279.71%	N/A
Revenue	$3.71B	Dec 31, 25
Revenue Estimate	$5.48B	N/A
Revenue Est. Change	+47.63%	N/A
Current Price	$239.56	Sep 18, 26
Price Target	$350.00	-
Price Tgt. Change	+46.10%	-

🔒 Log In To Unlock Full Data

EPS

ALNY EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	-$0.18	-$2.18	-1,118.68%
2025	$4.79	$2.33	-51.38%
2026	$8.85	N/A	+279.71%
2027	$12.47	N/A	+435.37%

Revenue

ALNY revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$2.24B	$2.25B	+0.57%
2025	$3.77B	$3.71B	-1.60%
2026	$5.48B	N/A	+47.63%
2027	$6.95B	N/A	+87.10%

🔒 Log In To Unlock Full Data

Performance

ALNY Performance
Metric	Value	Date
Price, 1Y	-47.02%	Sep 18, 26
Price, 3Y	+33.26%	Sep 18, 26
Market Cap, 1Y	-45.87%	Sep 18, 26
Market Cap, 3Y	+42.76%	Sep 18, 26
Revenue, 1Y	+65.19%	Dec 31, 25
Revenue, 3Y	+258.00%	Dec 31, 25
EPS, 1Y	+206.91%	Dec 31, 25
EPS, 3Y	+125.06%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

ALNY Technical Indicators
Metric	Value	Date
Current Price	$239.56	Sep 18, 26
SMA 200	$312.17	Sep 18, 26
SMA 50	$247.94	Sep 18, 26
EMA 200	$298.62	Sep 18, 26
EMA 50	$252.79	Sep 18, 26
MACD	-$0.43	Sep 18, 26
Beta	0.40	Sep 18, 26
ATR	$10.58	Sep 18, 26
14-Day RSI	45.37	Sep 18, 26
10-Day Volatility	36.90%	Sep 18, 26

Dividends

ALNY Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 18, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

ALNY Income & Profitability
Metric	Value	Date
Revenue	$3.71B	Dec 31, 25
EPS	$2.33	Dec 31, 25
Gross Profit	$3.03B	Dec 31, 25
Gross Margin	81.64%	Dec 31, 25
Operating Income	$501.58M	Dec 31, 25
Operating Margin	13.51%	Dec 31, 25
Net Income	$313.75M	Dec 31, 25
Net Margin	8.45%	Dec 31, 25
EBITDA	$557.24M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

ALNY Financial Health
Metric	Value	Date
Debt To Equity	3.76	Dec 31, 25
	2.76	Dec 31, 25
	2.71	Dec 31, 25
	-	Dec 31, 25
	6	Jun 30, 26
	4.36	Sep 18, 26

Valuations

ALNY Valuations
Metric	Value	Date
PE Ratio	40.45	Sep 18, 26
	6.67	Sep 18, 26
	23.67	Sep 18, 26
	30.09	Sep 18, 26
	-	N/A

Balance Sheet

ALNY Balance Sheet
Metric	Value	Date
Book Value	$789.18M	Dec 31, 25
	$2.91B	Dec 31, 25
	$5.03B	Dec 31, 25
	$4.05B	Dec 31, 25
	$4.24B	Dec 31, 25
	$1.47B	Dec 31, 25
Total Debt	$2.97B	Dec 31, 25
	$265.59M	Dec 31, 25
	$115.72M	Dec 31, 25

Expenses

ALNY Expenses
Metric	Value	Date
	$3.40B	Dec 31, 25
	$2.53B	Dec 31, 25
	$681.87M	Dec 31, 25
	$1.21B	Dec 31, 25
	$55.66M	Dec 31, 25
	$0.00	Dec 31, 25
	$9.41M	Dec 31, 25

Cash Flow

ALNY Cash Flow
Metric	Value	Date
	$524.08M	Dec 31, 25
	$436.33M	Dec 31, 25
	-$305.19M	Dec 31, 25
Capex	$58.70M	Dec 31, 25
	$465.38M	Dec 31, 25

Recent analyst updates

ALNY Recent analyst updates
Metric	Value	Date
Jefferies	→	Sep 8, 26
HC Wainwright & Co.	→	Sep 2, 26
BMO Capital	→	Aug 19, 26
Wells Fargo	→	Aug 14, 26
Truist Securities	→	Aug 4, 26
HC Wainwright & Co.	→	Aug 4, 26
Raymond James	→	Aug 3, 26
Citigroup	→	Aug 3, 26
Barclays	→	Aug 3, 26
Wells Fargo	→	Jul 31, 26

Analyst sentiment

Institutional ownership

No data

Screeners with ALNY

FAQ

What is the ticker symbol for Alnylam Pharmaceuticals, Inc.?: The ticker symbol for Alnylam Pharmaceuticals, Inc. is NASDAQ:ALNY
Does Alnylam Pharmaceuticals, Inc. pay dividends?: No, Alnylam Pharmaceuticals, Inc. does not pay dividends
What sector is Alnylam Pharmaceuticals, Inc. in?: Alnylam Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Alnylam Pharmaceuticals, Inc. in?: Alnylam Pharmaceuticals, Inc. is in the Biotechnology industry
What country is Alnylam Pharmaceuticals, Inc. based in?: Alnylam Pharmaceuticals, Inc. is headquartered in United States
When did Alnylam Pharmaceuticals, Inc. go public?: Alnylam Pharmaceuticals, Inc. initial public offering (IPO) was on June 1, 2004
Is Alnylam Pharmaceuticals, Inc. in the S&P 500?: No, Alnylam Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Alnylam Pharmaceuticals, Inc. in the NASDAQ 100?: Yes, Alnylam Pharmaceuticals, Inc. is included in the NASDAQ 100 index
Is Alnylam Pharmaceuticals, Inc. in the Dow Jones?: No, Alnylam Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Alnylam Pharmaceuticals, Inc. last earnings report?: Alnylam Pharmaceuticals, Inc.'s most recent earnings report was on July 30, 2026
When does Alnylam Pharmaceuticals, Inc. report earnings?: The next expected earnings date for Alnylam Pharmaceuticals, Inc. is October 29, 2026

Data Sources & References

ALNY Official Website www.alnylam.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1178670/000162828026007497/0001628280-26-007497-index.htm
List of NASDAQ 100 Companies www.nasdaq.com/market-activity/quotes/nasdaq-ndx-index
ALNY Profile on Yahoo Finance finance.yahoo.com/quote/ALNY
ALNY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alny